For Research Use Only. CJC-1295 and ipamorelin are intended exclusively for in vitro and preclinical animal research. They are not approved for human use, are not drugs, and should never be administered to humans. This guide does not describe any clinical, therapeutic, or human application.
What Makes a Research Grade CJC-1295 and Ipamorelin Supplier
Growth hormone secretagogue research requires consistent peptide quality, clear documentation of which CJC-1295 variant is being supplied, and a reliable combination product when the research protocol calls for the standard GHRH plus GHRP approach. A supplier that is positioned for this research segment has to handle all three requirements well.
The CJC-1295 variant distinction matters. As discussed in the DAC vs No DAC comparison article in this cluster, CJC-1295 with DAC and CJC-1295 without DAC are pharmacokinetically distinct compounds despite sharing the same base peptide sequence. A supplier that is not explicit about which variant is being provided is a weak sourcing partner because the research use case depends fundamentally on the variant choice.
The combination product format is the standard research approach for CJC-1295 plus ipamorelin research. Midwest Peptide supplies the CJC-1295/Ipamorelin Blend 10mg as a single research product that contains both peptides at appropriate ratios for the combined GHRH plus GHRP research paradigm. The blend format simplifies the experimental logistics because the researcher does not have to manage the mixing of two separate peptide stocks at defined ratios, and it ensures that the combination matches the published research literature that has documented the biology of these compounds together.
Sourcing Criteria for Research Grade CJC-1295 and Ipamorelin
The general sourcing criteria covered in the master research peptide sourcing guide apply to CJC-1295 and ipamorelin as much as to any other research peptide. Several criteria are worth emphasizing for this specific product category.
Third party certificate of analysis that distinguishes the peptides. The certificate for a blend product has to document both peptides separately. This requires analytical methods that can resolve and quantify the two peptides in the same sample. Midwest Peptide supplies the CJC-1295/Ipamorelin blend with third party certificates that cover both components with lot specific values.
Explicit identification of the CJC-1295 variant. The certificate should state clearly whether the supplied peptide is CJC-1295 No DAC or CJC-1295 DAC. The Midwest Peptide research blend uses the No DAC variant, which aligns with the dominant research literature and with the pulsatile profile that is typically desired for growth hormone secretagogue research.
Purity specification for both peptides. Both components should be supplied at research grade purity by HPLC. The individual purity values are on the certificate of analysis for the blend.
Mass confirmation of both peptides. Mass spectrometric identification should confirm both peptides against their theoretical masses. The CJC-1295 thirty amino acid sequence and the ipamorelin five amino acid sequence have distinct masses that are straightforward to confirm analytically.
Ratio documentation. The ratio of the two peptides in the blend should be defined and documented. This matters for reproducibility across studies and for comparison with the published literature that has used specific ratios.
Lot traceability. The blend should carry a lot number that traces back to the specific production batch, just as with any other research peptide.
Research use only compliance. The supplier should label the product for research use only and should not make health claims or imply human use. The research applications of these compounds are covered in the CJC-1295 / Ipamorelin Blend: What Researchers Need to Know, and the language is preclinical throughout.
Red Flags in CJC-1295 and Ipamorelin Sourcing
Several warning signs should remove a supplier from consideration for growth hormone secretagogue research peptides.
Ambiguous CJC-1295 variant identification. A supplier that simply lists "CJC-1295" without specifying DAC or No DAC is not providing the documentation clarity that serious research requires. The two variants are chemically and biologically distinct.
No documentation of the blend ratio. If the ratio of CJC-1295 to ipamorelin in a blend product is not documented, the research reproducibility is compromised.
Internal certificate only. A supplier that does not use a third party analytical laboratory for certificate generation is providing weaker documentation than research buyers should accept.
Health claims or implied human use. Any supplier that describes these compounds as therapeutic, that implies human dosing, or that makes any suggestion of a medical application is operating outside the research use only framework.
No specified purity values. Vague language without specific purity percentages indicates insufficient analytical rigor.
No physical address or customer support. A legitimate research peptide supplier operates from a known location with real customer support. Midwest Peptide operates from Mission, Kansas and provides the research support line at 636-734-2390.
What CJC-1295 and Ipamorelin Are Studied For in Research
Understanding the research applications helps clarify which features of the supply chain matter most for a given study. The Tesamorelin/Ipamorelin Blend in Research: Combining GHRH and GHRP Mechanisms covers the complete landscape, but a brief summary is useful.
The combination is used in rodent research models of growth hormone secretion, growth hormone pulse dynamics, and the downstream IGF-1 axis biology documented in the IGF-1 axis article in this cluster. The DAC vs No DAC comparison article explains why the No DAC variant is preferred for research that wants to preserve natural pulsatile signaling.
The combination is also studied in comparison with other GHRH analogs. The Tesamorelin GHRH Analog Chemistry: What Makes Tesamorelin Stable in Research in the tesamorelin cluster provides the comparative analysis for researchers who want to evaluate different GHRH options. Midwest Peptide supplies the Tesa/Ipa 10mg Blend as an alternative research formulation that uses tesamorelin as the GHRH component, which provides a research compatible option for studies that want to compare GHRH analogs within the same program.
Individual ipamorelin research is also supported. The standalone research use of ipamorelin, as discussed in the Ipamorelin Research: Selective GHRP and Ghrelin Receptor Binding Studies in this cluster, benefits from a supplier that can provide ipamorelin in defined research formats. The Midwest Peptide catalog includes standalone Ipamorelin 10mg for this purpose.
Frequently Asked Sourcing Questions
What CJC-1295 variant does Midwest Peptide supply? The standard research blend uses CJC-1295 No DAC, which is the variant aligned with the dominant published research literature on the combination.
What is the ratio of CJC-1295 to ipamorelin in the blend? The specific ratio is documented on the certificate of analysis for each lot. The ratio is selected to match the ratios used in the standard research protocols.
What is the purity specification? Both peptides in the blend are supplied at a minimum of ninety five percent HPLC purity. The lot specific values are on the certificate of analysis.
Is standalone ipamorelin available? Yes. Ipamorelin 10mg is available as a standalone research peptide for studies that use ipamorelin independently.
Is a tesamorelin based alternative available? Yes. The Tesa/Ipa 10mg Blend provides tesamorelin plus ipamorelin as an alternative research combination.
What is the shipping timeline? Domestic shipping from Mission, Kansas through ShipStation and UPS typically reaches continental United States locations within two to four business days with tracking.
What payment methods are accepted? Zelle (five percent discount), CashApp, Venmo, Azeban Pay for credit and debit cards, and Coinbase Commerce for cryptocurrency.
Can I request additional documentation? Yes. Research laboratories needing documentation beyond the standard certificate of analysis can contact the Midwest Peptide research support line at 636-734-2390.